Contenu disponible en anglais seulement.
Bulletin de la Bourse
Purpose Healthcare Innovation Yield ETF (HEAL) inscrit à la Bourse de Toronto
14 janvier 2022
Issuer: Purpose Healthcare Innovation Yield ETF (the "Purpose ETF")
| Security | Symbol | Issued and Outstanding Securities | Reserved Securities | Issue Price |
|---|---|---|---|---|
| ETF Units | HEAL | 50,000 | None | C$20.00 |
| Listing category: | Non-Corporate |
| Trading Currency: | CDN$ |
| Transaction: | Initial public offering (the "Offering") of ETF Units |
| Listing date: | January 17, 2022 (as at 5:01 p.m.) in anticipation of closing of the Offering |
| Anticipated closing date: | January 18, 2022 (prior to the opening) |
| Posted for trading date: | January 18, 2022 (at the opening) subject to confirmation of closing of the Offering |
| Other market(s): | None |
| Designated market maker: | National Bank Financial Inc. |
| Security ownership registration: | CDS book based system and Non-Certificated Issue |
| Investor relations: | Vanessa Fiorido Content Marketing Strategist Tel: 416-583-3850 vanessaf@purposeinvest.com - and - Vladimir Tasevski Chief Operating Officer Tel: 416 871-6454 vladt@purposeinvest.com |
| Incorporation: | A mutual fund established as a trust under the laws of the Province of Ontario pursuant to an amended and restated declaration of trust dated as of December 10, 2021. |
| Manager and Trustee: | Purpose Investments Inc. |
| Fiscal year end: | December 31 |
| Nature of business: | Purpose ETF seeks to provide unitholders with exposure to biotechnology and healthcare companies with: (i) the opportunity for capital appreciation; (ii) monthly cash distributions; and (iii) lower volatility of investment portfolio returns when compared to owning the underlying securities of the fund directly. Investments by the fund may be made globally. |
| Transfer agent and registrar: | TSX Trust Company at its principal office in Toronto. |
| Dividends: | The ETF expects to make distributions annually. |
| Sponsorship: | Not applicable |
| Disclosure documents: | Amendment No. 2 dated December 6, 2021 to the simplified prospectus dated October 4, 2021, (the "Prospectus"), as amended by Amendment No. 1 dated October 29, 2021 (together, the "Prospectus") and Amendment No. 2 dated December 6, 2021 to the annual information form dated October 4, 2021, as amended by Amendment No. 1 dated October 29, 2021 (together, the "AIF" and, together with the Prospectus, the "Disclosure Documents") which are available at www.SEDAR.com. Capitalized terms not otherwise defined herein are as defined in the Disclosure Documents. |
| Initial public offering: | 50,000 ETF Units will be issued at a subscription price of C$20.00 per ETF Unit. The ETF Units of the ETF are being issued and sold on a continuous basis and there is no maximum number of ETF Units that may be issued. |
| TSX contact: | Chris Birkett, Managing Director, Toronto Stock Exchange |